Healio
Healio

HCV Awareness

Healio spoke with experts about what awareness means in the HCV community, COVID-19’s impact on HCV elimination goals, health equity in the care of patients with HCV, the need for better screening and more.

Choose a Section
  • Julio Gutierrez, MD
  • Michael Saag, MD

    • Michael Saag, MD

    Healio spoke with Michael Saag, MD, associate dean for global health in the school of medicine, director of the UAB Center for AIDS Research and professor of medicine in the division of infectious diseases at the University of Alabama at Birmingham, about:

    • Hepatitis Awareness Month;
    • direct-acting antiviral agents;
    • treating HCV in special populations; and
    • the goal of testing everyone and treating all who test positive.

    Read more about

    hepatitis c virus
    direct acting antivirals
    disease elimination
    covid-19
    health equity
    sofosbuvir